International Journal of Clinical Medicine

Volume 5, Issue 4 (February 2014)

ISSN Print: 2158-284X   ISSN Online: 2158-2882

Google-based Impact Factor: 0.51  Citations  

Comparative Rates of Adverse Events with 2-Hour versus 4-Hour Infusion of Total Dose Intravenous Iron Polymaltose

HTML  Download Download as PDF (Size: 79KB)  PP. 145-148  
DOI: 10.4236/ijcm.2014.54025    3,339 Downloads   4,898 Views  Citations

ABSTRACT

Background and aim of the study: Patients with iron deficiency (ID) who are unable to tolerate or show sub-optimal response to oral iron therapy are candidates for parenteral iron therapy. This study evaluated the patient safety and tolerance of iron polymaltose given either as a 2-hour infusion or as a 4-hour infusion. Methods: A total of 243 patients with ID were randomized alternatively to receive iron polymaltose infusion either as a 2-hour infusion or as a 4-hour infusion. All patients received pre-medication with certizine hydrochloride 10 mg PO one-hour before infusion and hydrocortisone 50 mg IVI immediately before infusion. Infusion related adverse events/side-effects during the infusion and over the next seven days were documented and graded as mild, moderate or severe. Results: The age of the patients ranged from 17 years to 92 years (mean 55.5 yr); M:F = 1:3.5. One hundred and twenty-two patients were in the 2-hour arm (M:F = 1:5; mean age 52.9 yr) and 121 were in the 4-hour arm (M:F = 1:2.6; mean age 58.1 yr). Iron infusion therapy was generally well tolerated by patients in both arms. Adverse events/side effects were documented in 14 patients in each arm (22 events in the 2-hour arm and 20 in the 4-hour arm) and included aches and pains, cannula-site pain/swelling, nausea, abdominal cramps, rash, vagal response, metallic taste, hot flushes and headaches. In most patients, these events were mild and none had any severe events. Conclusion: The incidence of adverse events with 2-hour infusion of iron polymaltose is similar to that observed with 4-hour infusion of iron polymaltose.

Share and Cite:

A. Manoharan, W. Alexander, R. Ramakrishna, J. Legge and J. Uebel, "Comparative Rates of Adverse Events with 2-Hour versus 4-Hour Infusion of Total Dose Intravenous Iron Polymaltose," International Journal of Clinical Medicine, Vol. 5 No. 4, 2014, pp. 145-148. doi: 10.4236/ijcm.2014.54025.

Cited by

[1] A Budget Impact Analysis of Iron Polymaltose and Ferric Carboxymaltose Infusions
2021
[2] Iron polymaltose infusion therapy during pregnancy
Internal medicine journal, 2018
[3] Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia
2017
[4] Efficacy and safety of ultra rapid iron polymaltose infusion during general anaesthesia.
Anaesthesia & Intensive Care, 2017
[5] Intravenous iron vs blood for acute post-partum anaemia (IIBAPPA): a prospective randomised trial
2017
[6] Ironing out iron infusions–does premedication reduce adverse reactions during iron polymaltose infusion: a single‐centre retrospective review
Journal of Pharmacy Practice and Research, 2016
[7] Safety of rapid infusion of iron polymaltose: comparative study in 300 patients
Journal of Pharmacy Practice and Research, 2016

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.